Conclusions

• In a basal state, pump patients have significantly better glycemic control than patients treated with glargine

• Pump therapy mimics basal insulin variations of a normal pancreas, creating more stability in blood glucose than glargine

• Pump patients spent 54% more time in the
  study’s target glucose range overnight

• Glargine patients experienced nearly 3 fold
  the frequency of hypoglycemia

Previous slide

Next slide

Back to first slide

View graphic version